• SyncroPatch 384/768PE

    APC with highest throughput on the market
  • SyncroPatch 384/768PE

    384 cells in parallel => upgradable to 768
  • SyncroPatch 384/768PE

    True HTS AND Gigaohm seals
  • SyncroPatch 384/768PE

    True internal perfusion with continuous data acquisition
  • SyncroPatch 384/768PE

    Assay flexibility via high tech

NaV1.7 - "Pharmacology on rNaV1.7 performed on Nanion‘s SyncroPatch 96"

icon sp96   SyncroPatch 96 application note, (a predecessor model of the SyncroPatch 384PE)   logo pdf   (0.6 MB)
Cells were kindly provided by Millipore.

Summary:

NaV1.7 is an increasingly interesting target for drug development due to its role in pain. In this Application Note measurements are presented to demonstrate the accuracy and robustness of pharmacological NaV1.7 data that can be generated with Nanion’s SyncroPatch 96.

Back to Overview

Contact Us

Please type your full name.
Invalid email address.
Invalid Input
Invalid Input
Nanion Technologies GmbH

Ganghoferstr. 70A
D-80339 Munich - Germany
info@nanion.de